Preclinical Evaluation of ⁶⁸Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis

Introduction. The early detection of tumor growth remains one of the most important tasks of diagnostic nuclear medicine. The vascular growth being created malignant neoplasms is a good target for the purpose. The molecular participants in the process are gallium-68 labeled vector to the delivery of...

全面介紹

書目詳細資料

Principais autores:	O. E. Klementyeva, A. B. Bruskin, A. S. Lunev, M. G. Rakhimov, K. A. Luneva, G E. Codina
格式:	Artigo
語言:	Russo
出版:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-08-01
叢編:	Разработка и регистрация лекарственных средств
主題:	pet diagnostics tumor angiogenesis gallium-68 «vascular, <sup>68</sup>ga» xenograft rgd
在線閱讀:	https://www.pharmjournal.ru/jour/article/view/833
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!